Ethical Concerns about Psilocybin Intellectual Property

Since a 1957 exposé in Life Magazine, chemical compounds derived from Psilocybe mushrooms have been the focus of dozens of attempted and successful patents, most recently to treat depression. Regrettably, the Mazatec indigenous communities who stewarded these traditional medicines for millenia are...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	ACS pharmacology & translational science 2021-04, Vol.4 (2), p.573-577
Hauptverfasser:	Gerber, Konstantin, Flores, Inti García, Ruiz, Angela Christina, Ali, Ismail, Ginsberg, Natalie Lyla, Schenberg, Eduardo E
Format:	Artikel
Sprache:	eng
Schlagworte:	Viewpoint
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	577
container_issue	2
container_start_page	573
container_title	ACS pharmacology & translational science
container_volume	4
creator	Gerber, Konstantin Flores, Inti García Ruiz, Angela Christina Ali, Ismail Ginsberg, Natalie Lyla Schenberg, Eduardo E
description	Since a 1957 exposé in Life Magazine, chemical compounds derived from Psilocybe mushrooms have been the focus of dozens of attempted and successful patents, most recently to treat depression. Regrettably, the Mazatec indigenous communities who stewarded these traditional medicines for millenia are not party to any of these patents, despite a number of international treaties asserting indigenous rights to their intangible cultural heritage.
doi_str_mv	10.1021/acsptsci.0c00171
format	Article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8033603</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2514596287</sourcerecordid><originalsourceid>FETCH-LOGICAL-a433t-62eb90bb25e152c87086afc4f237202ba46019cdc734e9cc8256d833bd7fd4973</originalsourceid><addsrcrecordid>eNp1kM9LwzAUx4MobszdPUmPHux8SdomvQgypg4G7qDnkKapy-iamqTC_ns79oN58BBe4H2_3_feB6FbDBMMBD9K5dvglZmAAsAMX6AhSVka5xj45dl_gMberwGAAFCcwzUaUMozwDwbIjYLK6NkHU1to7RrfCQL24Vo6U1t1bYwTTRvgq5rrULXy5bOttqF7Q26qmTt9fhQR-jzZfYxfYsX76_z6fMilgmlIc6ILnIoCpJqnBLFGfBMViqpCGUESCGTfo9clYrRROdKcZJmJae0KFlVJjmjI_S0z227YqNLpZvgZC1aZzbSbYWVRvztNGYlvuyP4EBp1r8Ruj8EOPvdaR_ExnjVHyQbbTsvSIqTNM8I382CvVQ5673T1WkMBrFDLo7IxQF5b7k7X-9kOALuBQ97QW8Va9u5pqf1f94vb6qOCg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2514596287</pqid></control><display><type>article</type><title>Ethical Concerns about Psilocybin Intellectual Property</title><source>PubMed Central</source><source>American Chemical Society Journals</source><creator>Gerber, Konstantin ; Flores, Inti García ; Ruiz, Angela Christina ; Ali, Ismail ; Ginsberg, Natalie Lyla ; Schenberg, Eduardo E</creator><creatorcontrib>Gerber, Konstantin ; Flores, Inti García ; Ruiz, Angela Christina ; Ali, Ismail ; Ginsberg, Natalie Lyla ; Schenberg, Eduardo E</creatorcontrib><description>Since a 1957 exposé in Life Magazine, chemical compounds derived from Psilocybe mushrooms have been the focus of dozens of attempted and successful patents, most recently to treat depression. Regrettably, the Mazatec indigenous communities who stewarded these traditional medicines for millenia are not party to any of these patents, despite a number of international treaties asserting indigenous rights to their intangible cultural heritage.</description><identifier>ISSN: 2575-9108</identifier><identifier>EISSN: 2575-9108</identifier><identifier>DOI: 10.1021/acsptsci.0c00171</identifier><identifier>PMID: 33860186</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Viewpoint</subject><ispartof>ACS pharmacology & translational science, 2021-04, Vol.4 (2), p.573-577</ispartof><rights>2021 American Chemical Society</rights><rights>2021 American Chemical Society.</rights><rights>2021 American Chemical Society 2021 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a433t-62eb90bb25e152c87086afc4f237202ba46019cdc734e9cc8256d833bd7fd4973</citedby><cites>FETCH-LOGICAL-a433t-62eb90bb25e152c87086afc4f237202ba46019cdc734e9cc8256d833bd7fd4973</cites><orcidid>0000-0001-7111-9891</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acsptsci.0c00171$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acsptsci.0c00171$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,2763,27074,27922,27923,53789,53791,56736,56786</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33860186$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gerber, Konstantin</creatorcontrib><creatorcontrib>Flores, Inti García</creatorcontrib><creatorcontrib>Ruiz, Angela Christina</creatorcontrib><creatorcontrib>Ali, Ismail</creatorcontrib><creatorcontrib>Ginsberg, Natalie Lyla</creatorcontrib><creatorcontrib>Schenberg, Eduardo E</creatorcontrib><title>Ethical Concerns about Psilocybin Intellectual Property</title><title>ACS pharmacology & translational science</title><addtitle>ACS Pharmacol. Transl. Sci</addtitle><description>Since a 1957 exposé in Life Magazine, chemical compounds derived from Psilocybe mushrooms have been the focus of dozens of attempted and successful patents, most recently to treat depression. Regrettably, the Mazatec indigenous communities who stewarded these traditional medicines for millenia are not party to any of these patents, despite a number of international treaties asserting indigenous rights to their intangible cultural heritage.</description><subject>Viewpoint</subject><issn>2575-9108</issn><issn>2575-9108</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kM9LwzAUx4MobszdPUmPHux8SdomvQgypg4G7qDnkKapy-iamqTC_ns79oN58BBe4H2_3_feB6FbDBMMBD9K5dvglZmAAsAMX6AhSVka5xj45dl_gMberwGAAFCcwzUaUMozwDwbIjYLK6NkHU1to7RrfCQL24Vo6U1t1bYwTTRvgq5rrULXy5bOttqF7Q26qmTt9fhQR-jzZfYxfYsX76_z6fMilgmlIc6ILnIoCpJqnBLFGfBMViqpCGUESCGTfo9clYrRROdKcZJmJae0KFlVJjmjI_S0z227YqNLpZvgZC1aZzbSbYWVRvztNGYlvuyP4EBp1r8Ruj8EOPvdaR_ExnjVHyQbbTsvSIqTNM8I382CvVQ5673T1WkMBrFDLo7IxQF5b7k7X-9kOALuBQ97QW8Va9u5pqf1f94vb6qOCg</recordid><startdate>20210409</startdate><enddate>20210409</enddate><creator>Gerber, Konstantin</creator><creator>Flores, Inti García</creator><creator>Ruiz, Angela Christina</creator><creator>Ali, Ismail</creator><creator>Ginsberg, Natalie Lyla</creator><creator>Schenberg, Eduardo E</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7111-9891</orcidid></search><sort><creationdate>20210409</creationdate><title>Ethical Concerns about Psilocybin Intellectual Property</title><author>Gerber, Konstantin ; Flores, Inti García ; Ruiz, Angela Christina ; Ali, Ismail ; Ginsberg, Natalie Lyla ; Schenberg, Eduardo E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a433t-62eb90bb25e152c87086afc4f237202ba46019cdc734e9cc8256d833bd7fd4973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Viewpoint</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gerber, Konstantin</creatorcontrib><creatorcontrib>Flores, Inti García</creatorcontrib><creatorcontrib>Ruiz, Angela Christina</creatorcontrib><creatorcontrib>Ali, Ismail</creatorcontrib><creatorcontrib>Ginsberg, Natalie Lyla</creatorcontrib><creatorcontrib>Schenberg, Eduardo E</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>ACS pharmacology & translational science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gerber, Konstantin</au><au>Flores, Inti García</au><au>Ruiz, Angela Christina</au><au>Ali, Ismail</au><au>Ginsberg, Natalie Lyla</au><au>Schenberg, Eduardo E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ethical Concerns about Psilocybin Intellectual Property</atitle><jtitle>ACS pharmacology & translational science</jtitle><addtitle>ACS Pharmacol. Transl. Sci</addtitle><date>2021-04-09</date><risdate>2021</risdate><volume>4</volume><issue>2</issue><spage>573</spage><epage>577</epage><pages>573-577</pages><issn>2575-9108</issn><eissn>2575-9108</eissn><abstract>Since a 1957 exposé in Life Magazine, chemical compounds derived from Psilocybe mushrooms have been the focus of dozens of attempted and successful patents, most recently to treat depression. Regrettably, the Mazatec indigenous communities who stewarded these traditional medicines for millenia are not party to any of these patents, despite a number of international treaties asserting indigenous rights to their intangible cultural heritage.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>33860186</pmid><doi>10.1021/acsptsci.0c00171</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-7111-9891</orcidid><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 2575-9108
ispartof	ACS pharmacology & translational science, 2021-04, Vol.4 (2), p.573-577
issn	2575-9108 2575-9108
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8033603
source	PubMed Central; American Chemical Society Journals
subjects	Viewpoint
title	Ethical Concerns about Psilocybin Intellectual Property
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T15%3A30%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ethical%20Concerns%20about%20Psilocybin%20Intellectual%20Property&rft.jtitle=ACS%20pharmacology%20&%20translational%20science&rft.au=Gerber,%20Konstantin&rft.date=2021-04-09&rft.volume=4&rft.issue=2&rft.spage=573&rft.epage=577&rft.pages=573-577&rft.issn=2575-9108&rft.eissn=2575-9108&rft_id=info:doi/10.1021/acsptsci.0c00171&rft_dat=%3Cproquest_pubme%3E2514596287%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2514596287&rft_id=info:pmid/33860186&rfr_iscdi=true